AMXI-5001, a novel dual parp1/2 and microtubule polymerization inhibitor for the treatment of human cancers.

Lemjabbar-Alaoui, Hassan; Peto, Csaba J; Yang, Yi-Wei; Jablons, David M.

Afiliação

Lemjabbar-Alaoui H; Department of Surgery, Thoracic Oncology Program, University of California San Francisco 94143, USA.
Peto CJ; Department of Surgery, Thoracic Oncology Program, University of California San Francisco 94143, USA.
Yang YW; Department of Surgery, Thoracic Oncology Program, University of California San Francisco 94143, USA.
Jablons DM; Department of Surgery, Thoracic Oncology Program, University of California San Francisco 94143, USA.

Am J Cancer Res ; 10(8): 2649-2676, 2020.

Article em En | MEDLINE | ID: mdl-32905466